Anti-Prokineticin1 Suppresses Liver Metastatic Tumors in a Mouse Model of Colorectal Cancer with Liver Metastasis

Multidisciplinary treatment for colorectal cancer (CRC) has undergone significant advances, and molecularly targeted drugs have substantially improved patient prognosis. However, one problem with current molecularly targeted therapeutics is that they must be used in combination with anticancer agent...

Descrición completa

Detalles Bibliográficos
Main Authors: Hiroko Kono, Takanori Goi, Takayuki Matsunaka, Kenji Koneri
Formato: Artigo
Idioma:English
Publicado: MDPI AG 2023-12-01
Series:Current Issues in Molecular Biology
Subjects:
Acceso en liña:https://www.mdpi.com/1467-3045/46/1/4